IONS

Ionis Pharmaceuticals (IONS) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.

SEC Filings

Roche's Sefaxersen Cuts Protein Loss 43.1% In Late-Stage Kidney Trial Of Ionis-Discovered Drug

Ionis said the once-monthly shot beat placebo on its main goal in IgA nephropathy, with no new safety signals.

SEC Filings

FDA Approves Hibsago, GSK's Hepatitis B Drug From Ionis, With 10-12% Royalties And A Boxed Warning

The six-month treatment showed a 19% functional cure rate in pooled late-stage trials, and its label warns of liver flares and low platelets.